+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Asia-Pacific Autoimmune Disease Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4591824
  • Report
  • March 2020
  • Region: Asia Pacific
  • 110 pages
  • Mordor Intelligence


  • Abbott Laboratories
  • BioMerieux
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer, Inc.
  • Siemens AG
  • Thermo Fisher Scientific
The treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physician for better treatment of the disease. All the diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patient will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, physician collaborates with that laboratory and suggests patient to get their tests done from there and the results will directly be sent to the physician. Furthermore, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnostics market.

Key Market Trends

Immunologic Assays Segment is Expected to Show Better Growth During the Forecast Years

Based on Diagnosis, the market is segmented into Regular Laboratory Tests, Inflammatory Markers, Immunologic Assays, Antibody Tests and Other Tests. The factors responsible for the growth of the market include cost-effectiveness, growth in the biotechnology and pharmaceutical sectors, and high sensitivity and specificity of immunoassays. When compared to conventional tests, immunologic assays have been proven to provide highly accurate results, even with very small samples.

Immunologic reactions are highly specific, as they can take place only in the presence of proper immunologic agents. This high specificity indicates high accuracy in results, enabling high sensitivity in the detection of diseases. It helps in easy detection and eliminates the need for secondary verification, which ultimately saves costs. Hence, owing to these factors, the segment is expected to show better growth in the forecast period.

Competitive Landscape

The market comprises of major market players, and these players are focusing on R&D activities and significant growth strategies. The major players into the Asia-Pacific autoimmune disease diagnostics market are Abbott Laboratories, BioMerieux, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Siemens AG, Trinity Biotech and Thermo Fisher Scientific.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • 3 months of analyst support.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Abbott Laboratories
  • BioMerieux
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer, Inc.
  • Siemens AG
  • Thermo Fisher Scientific
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Public Awareness about Autoimmune Diseases
4.2.2 Partnerships with Physicians and Clinical Laboratories
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Disease Type
5.1.1 Systemic Autoimmune Disease Rheumatoid Arthritis Psoriasis Systemic Lupus Erythematosus (SLE) Multiple Sclerosis Other Systemic Autoimmune Diseases
5.1.2 Localized Autoimmune Disease Inflammatory Bowel Disease Type 1 Diabetes Thyroid Other Localized Autoimmune Diseases
5.2 By Diagnosis
5.2.1 Regular Laboratory Tests
5.2.2 Inflammatory Markers
5.2.3 Immunologic Assays
5.2.4 Antibody Tests
5.2.5 Other Tests
5.3 Geography
5.3.1 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 BioMerieux
6.1.3 Bio-Rad Laboratories, Inc.
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 PerkinElmer, Inc.
6.1.6 Siemens AG
6.1.7 Trinity Biotech
6.1.8 Thermo Fisher Scientific

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • BioMerieux
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer, Inc.
  • Siemens AG
  • Trinity Biotech
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown